65 related articles for article (PubMed ID: 729470)
1. [The influence of hormonal contraceptives in the spectrum of free plasma amino acids].
Klinger G; Gruhn K
Dtsch Gesundheitsw; 1978; 33(50):2373-7. PubMed ID: 729470
[TBL] [Abstract][Full Text] [Related]
2. [Effect of contraceptives on the digestibility of dietary protein and nitrogen balance].
Gruhn K; Hennig A; Klinger G; Krause G
Nahrung; 1981; 25(8):779-88. PubMed ID: 7290175
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
4. [The behavior of serum total protein and protein fractions during the use of various hormonal contraceptives].
Klinger G; Scheler R; Tarnick M; Krause G; Hesse A; Carol W
Dtsch Gesundheitsw; 1977; 32(51):2418-23. PubMed ID: 73442
[TBL] [Abstract][Full Text] [Related]
5. [Oral contraceptive agents and antithrombin III].
Kamenov V; Nalbanski B
Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
[TBL] [Abstract][Full Text] [Related]
6. [The value of the gingival cytogram for the evaluation of hormonal contraceptives].
Klinger G; Sommer K; Klinger G
Stomatol DDR; 1979 Jan; 29(1):11-5. PubMed ID: 373163
[TBL] [Abstract][Full Text] [Related]
7. Transcortin as an indicator of estrogenic potency in oral contraceptives.
Carol W; Börner A; Klinger G; Greinke C
Endokrinologie; 1980 Mar; 75(2):167-72. PubMed ID: 6156820
[TBL] [Abstract][Full Text] [Related]
8. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
9. [Clinico-laboratory research on the pharmacodynamic characteristics of Rigevidon].
Korkhov VV; Nikanorova SA
Farmakol Toksikol; 1987; 50(1):97-100. PubMed ID: 3556564
[TBL] [Abstract][Full Text] [Related]
10. [Detection of N-acetylneuraminic acid with long-time application of hormonal contraceptives (author's transl)].
Klinger G; Kunstmann FW; Stelzner A
Zentralbl Gynakol; 1981; 103(1):36-40. PubMed ID: 7053175
[TBL] [Abstract][Full Text] [Related]
11. [Time course of inhibition of caffeine elimination in response to the oral depot contraceptive agent Deposiston. Hormonal contraceptives and caffeine elimination].
Meyer FP; Canzler E; Giers H; Walther H
Zentralbl Gynakol; 1991; 113(6):297-302. PubMed ID: 2058339
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
13. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
[TBL] [Abstract][Full Text] [Related]
14. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
Jespersen J; Kluft C
Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
[TBL] [Abstract][Full Text] [Related]
15. [Long-term effect of hormonal contraceptives on the behavior of serum lipids].
Klinger G; Carol W; Hoppe H; Müller B; Bonow A
Zentralbl Gynakol; 1977; 99(5):271-6. PubMed ID: 194435
[TBL] [Abstract][Full Text] [Related]
16. [Central and peripheral actions of an oral contraceptive with reduced oestrogen content (author's transl)].
Schneider WH; Schmid R; Spona J
Wien Klin Wochenschr; 1977 Apr; 89(9):311-3. PubMed ID: 855349
[TBL] [Abstract][Full Text] [Related]
17. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
18. [Impact of synthetic sexual steroids on blood volume (author's transl)].
Klinger G; Stoll W; Zinner G; Krause G; Carol W
Zentralbl Gynakol; 1982; 104(6):343-8. PubMed ID: 7046293
[TBL] [Abstract][Full Text] [Related]
19. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
[TBL] [Abstract][Full Text] [Related]
20. Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone.
Gupta KC; Joshi JV; Hazari K; Pohujani SM; Satoskar RS
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):511-3. PubMed ID: 7174153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
